Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

725 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[Risk factors of the occurrence of cerebral toxoplasmosis in patients with HIV infection. Definition of indications of primary prevention. Proposals of the Toxoplasmosis and other protozoan infections Group. Coordinated action N.5 - 1996 February].
Leport C, Ambroise-Thomas P, Bazin C, Chène G, Derouin F, Katlama C, Mayaud C, Pelloux H, Raffi F, Vildé JL. Leport C, et al. Among authors: raffi f. Presse Med. 1996 Mar 30;25(11):519-20. Presse Med. 1996. PMID: 8731794 French. No abstract available.
A randomized trial of three maintenance regimens given after three months of induction therapy with zidovudine, lamivudine, and indinavir in previously untreated HIV-1-infected patients. Trilège (Agence Nationale de Recherches sur le SIDA 072) Study Team.
Pialoux G, Raffi F, Brun-Vezinet F, Meiffrédy V, Flandre P, Gastaut JA, Dellamonica P, Yeni P, Delfraissy JF, Aboulker JP. Pialoux G, et al. Among authors: raffi f. N Engl J Med. 1998 Oct 29;339(18):1269-76. doi: 10.1056/NEJM199810293391802. N Engl J Med. 1998. PMID: 9791142 Free article. Clinical Trial.
Definition of virologic response and the type of assay used for quantification of viral load may influence the proportion of responders to antiretroviral therapy. APROCO Study Group.
Le Moing V, Chêne G, Masquelier B, Sicard D, Brun-Vézinet F, Reynes J, Raffi F. Le Moing V, et al. Among authors: raffi f. J Acquir Immune Defic Syndr. 2000 May 1;24(1):82-3. doi: 10.1097/00126334-200005010-00016. J Acquir Immune Defic Syndr. 2000. PMID: 10877502 No abstract available.
Hepatitis C virus co-infection is a negative prognostic factor for clinical evolution in human immunodeficiency virus-positive patients.
Piroth L, Grappin M, Cuzin L, Mouton Y, Bouchard O, Raffi F, Rey D, Peyramond D, Gourdon F, Drobacheff C, Lombart ML, Lucht F, Besnier JM, Bernard L, Chavanet P, Portier H. Piroth L, et al. Among authors: raffi f. J Viral Hepat. 2000 Jul;7(4):302-8. doi: 10.1046/j.1365-2893.2000.00227.x. J Viral Hepat. 2000. PMID: 10886541
[Mycobacterium avium complex disease in HIV seropositive patients: incidence and risk factors before and after the introduction of highly active antiretroviral treatments. Clinical Epidemiology Group of the Information and Care Center for Human Immunodeficiency].
Mary-Krause M, Rabaud C, Jouan M, Obadia M, de la Blanchardière A, Raffi F, May T. Mary-Krause M, et al. Among authors: raffi f. Pathol Biol (Paris). 2000 Jun;48(5):495-504. Pathol Biol (Paris). 2000. PMID: 10949848 French.
725 results